21st.BIO is a startup. Brouky records 1 investor associated with the company.
21st Solutions develops AmyletiX, a technology that improves delivery and bioavailability of hydrophobic ingredients for pharmaceutical, nutraceutical, cosmetic, food & beverage, and pet care applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.